2.Research Progress on Bacillus thuringiensis Chitinase
Wei LU ; Jun CAI ; Yue-Hua CHEN ;
Microbiology 1992;0(01):-
The leading bioregional pesticide,Bacillus thuringiensis,is accepted by the public and widely used biopesticide in the world.B. thuringiensis chitinase may contribute to the biocontrol of phytopathogenic fungi and enhance insecticidal activity.It helps to take full advan- tage of Bt and upgrade the efficiency.This paper reviews the progresses of B.thuringiensis chitinase.
3.One case report of Vogt-Koyanagi-Halada syndrome misdiagnosed of sudden hearing loss.
Wei HUANG ; Heying YUE ; Hua HU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(13):1000-1000
Vogt-Koyanagi-Halada syndrome is an autoimmune disease attacking melanocytes, which involves eye, ear, meninge and skin. Patient offen has uveitis and extraocular symptoms and signs and the misdiagnosis of missed diagnosis of VKHS is very common. Patients have good prognosis after hormone therapy.
Adult
;
Diagnostic Errors
;
Hearing Loss, Sudden
;
diagnosis
;
Humans
;
Male
;
Uveomeningoencephalitic Syndrome
;
diagnosis
4.One case of hereditary angioneurotic laryngeal edema.
Wei HUANG ; Heying YUE ; Hua HU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2013;27(21):1222-1222
Hereditary angioneurotic laryngeal edema (HALE) is an autosomal dominant hereditary disease in which there is a decrease or defect in the C1 inhibitor (C1-INH). The pathophysiology of HALE is characterized by recurrent spontaneous episodes of transient edema of the laryngeal mucose and submucosal tissue with remission at irregular. Patients may die because of a life-threatening acute upper airway obstruction caused by laryngeal edema. HALE was diagnosed on the clinical symptoms, family history, and markedly decreased serum C1-INH activity and C1-INH protein.
Angioedemas, Hereditary
;
diagnosis
;
Complement C1 Inactivator Proteins
;
analysis
;
metabolism
;
Complement C1 Inhibitor Protein
;
Humans
;
Laryngeal Edema
;
diagnosis
;
Recurrence
5.Incidence of depression and its related factors in cryptorchidism patients after surgical treatment.
Ming XI ; Lu CHENG ; Yue-ping WAN ; Wei HUA
National Journal of Andrology 2015;21(1):57-60
OBJECTIVETo investigate the incidence of depression and its etiological factors in patients with cryptorchidism 6-16 years after surgical treatment.
METHODSUsing Self-Rating Depression Scale and Correlation Factor Questionnaire, we investigated the incidence of depression symptoms among 70 patients with cryptorchidism 6-16 years after surgical treatment and another 70 healthy males as controls, and analyzed the related factors of depression symptoms.
RESULTSThe incidence rate of depression symptoms was 50% in the cryptorchidism patients postoperatively, extremely significantly higher than 4.3% in the control group (χ2 = 23.5, P <0.01). Multiple stepwise regression analysis showed that the main risk factors of depression symptoms were worries about natural fertility (F = 15.8992, P <0.01), dissatisfaction with scrotal appearance (F = 4.6003, P <0.05), and the status of being married (F = 4.1002, P <0.05).
CONCLUSIONSymptoms of depression often occur in cryptorchidism patients after operation, and the major etiological factors are infertility, dissatisfaction with scrotal appearance, and the status of being married.
Adult ; Body Image ; psychology ; Case-Control Studies ; Cryptorchidism ; psychology ; surgery ; Depression ; epidemiology ; etiology ; Female ; Humans ; Incidence ; Infertility, Male ; psychology ; Male ; Marital Status ; Multivariate Analysis ; Risk Factors ; Scrotum ; pathology ; Surveys and Questionnaires ; Time Factors
6.Diagnostic value of CT-guided extrapleural locating transthoracic automated cutting needle biopsy of lung lesions.
Yue-hua WEI ; Mei-yan LIAO ; Li-ying XU
Chinese Journal of Oncology 2011;33(6):473-475
Adenocarcinoma
;
diagnosis
;
pathology
;
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Biopsy, Needle
;
methods
;
Carcinoma, Squamous Cell
;
diagnosis
;
pathology
;
False Negative Reactions
;
Female
;
Granuloma
;
diagnosis
;
pathology
;
Humans
;
Lung Diseases
;
diagnosis
;
pathology
;
Lung Neoplasms
;
diagnosis
;
pathology
;
Male
;
Middle Aged
;
Radiography, Interventional
;
Tomography, X-Ray Computed
;
Tuberculosis, Pulmonary
;
diagnosis
;
pathology
;
Young Adult
7.The effects of recombinant human endostatin on adjuvant arthritis in rats
Li YUE ; Hua WANG ; Lihua LIU ; Yuxian SHEN ; We WEI
Chinese Pharmacological Bulletin 1987;0(03):-
AIMTo investigate the effects of the recombina nt human endostatin on adjuvant arthritis (AA) in rats and its mechanisms. METHODSThe model of rat AA was induced by injection of intradermal CFA. ConA and LPS induce d splencytes proliferation was examined by MTT asssy and the activities of inter leukin-1 (IL-1) and IL-2 were measured by the method of thymocytes prolifera tion. Synoviocytes were dispersed with incubation of collagenase and trypsin, an d IL-1, TNF production of synoviocytes was estimated with radio-immunity assay . RESULTSThe secondary inflammation of AA rats appeared on the 1 0th day after injection of CFA. The therapeutic administration of endostatin (0 1, 0 5, 2 5 mg?kg -1 ?d -1 , sc, ?7 d) was given at that time(d 10). It was found that endostatin significantly inhibited the secondary paw swel ling. The increased ConA-induced splenic lymphocyte proliferation reaction and the activated IL-1 and IL-2 activity of AA rats was reversed by the treatment with endostatin. Meanwhile,IL-1 produced by PM? was increased. Endostatin inh ibited IL-1 production from PM? and IL-1 and reduced TNF level of Synoviocyte s in AA rats. CONCLUSIONThe recombinant human endostatin has the rapeutical effect on AA rats, its mechanisms is related to its immunoregulative function.
8.Preterm Rupture of Fetal Membranes and Neonatal Respiratory Distress Syndrome in Premature Infants
zhi-wei, LIU ; yue-hua, SHEN ; qing-sheng, CHEN
Journal of Applied Clinical Pediatrics 1992;0(06):-
24 hours) and versus control group(
9.Analysis of varieties and standards of labiatae medicinal plants used in Tibetan medicine.
Jun-wei HE ; Lan CAO ; Hua-rong ZHOU ; Wei-hong ZHONG ; Guo-yue ZHONG
China Journal of Chinese Materia Medica 2015;40(7):1419-1424
In this paper, an analysis was made on the varieties and standards of labiatae medicinal plants used in Tibetan medicine. The results showed 71 species of labiatae plants in 21 genera (including varieties) recorded in relevant literatures, involving 44 varieties of medicinal materials. Specifically, seven species (9.9%) were intersected with traditional Chinese medicines (TCM), 19 varieties (43%) were recorded in Chinese medicinal material standards at all levels, and 27 species (38%) were source plants. In Tibetan medicine standards and literatures, there are great differences between Tibetan names and translated Chinese names and among varieties of source plants. Apart from a few of varieties intersected with traditional Chinese medicines had complete standards and regulations in Chinese Pharmacopoeia, most of species only had characters, microscopic, physical and chemical identifications in Standards Issued by Ministry of Health-Tibetan Medicine, Tibetan Medicine Standard and local standards. Therefore, the Tibetan medicinal material variety-source specification and quality standard system shall be promoted on the basis of literatures research, investigations for resources and current applications and modern pharmaceutical studies.
Drugs, Chinese Herbal
;
chemistry
;
pharmacology
;
Humans
;
Lamiaceae
;
chemistry
;
classification
;
Medicine, Tibetan Traditional
;
standards
;
Phytotherapy
;
standards
;
Plants, Medicinal
;
chemistry
;
classification
10.Protective effect of edaravone against hepatic ischemia-reperfusion injry in small-for-size rat liver grafts
Jun SONG ; Wei XU ; Wei FU ; Zhiyuan HUA ; Aihua YAO ; Yue YU ; Xiangnong LI ; Xuehao WANG
Chinese Journal of Organ Transplantation 2010;31(5):300-303
Objective To investigate the protective effect of edaravone against ischemiareperfusion injury in small-for-size rat liver grafts and its possible mechanisms. Methods 40 % small-for-size rat liver transplantation model was established by using modified two-cuff technique, adult male SD rats were used as donors and recipients, and 16 recipient rats were randomly divided into two groups (8 cases in each group), saline control group (control group) and edaravone treatment group (ED group). In the ED group, 3 mg/kg edaravone was given intravenously via penile vein 30 min before transplantation in the recipients. The same amount of saline was given in the control group at the same time points. Serum hepatic function (AST and ALT) and histopathological changes were analyzed; the contents of MDA and SOD, and hepatic myeloperoxidase (MPO) activity in liver grafts after 6 h were determined; and TNF-α levels at 6th h after reperfusion were measured by using enzyme-linked immunosorbent assay (ELISA method). Results As compared with control group,serum AST and ALT levels were significantly reduced at the 6th h after reperfusion in ED group (AST: 825. 50 5±72. 87 vs 1188. 03 ± 124. 04; ALT. 687. 40 5±72. 21 vs 988. 66 ± 91.07, P<0. 01 ).The content of MDA was lower and SOD level was higher in ED group significantly than in control group (P<0. 01). As compared with control group, hepatic TNF-α levels and MPO activity at the 6th h after reperfusion were significantly decreased in ED group (P<0. 01 ). Histopathological analysis revealed disruption of lobular architecture, apparent hepatocelluar degeneration accompanied by focal necrosis, significant edema, congestion and inflammatory cell infiltration in periportal area at the 6th h after reperfusion in control group, but minimal liver damage was observed in ED group. Conclusion Edaravone could ameliorate early ischemia-reperfusion injury in small-for-size liver grafts significantly.The protective mechanisms were mediated in part by increasing antioxidant ability, inhibiting lipid peroxidation, and down-regulating inflammatory reaction.